Diversified Trust CO Corcept Therapeutics Inc Transaction History

Diversified Trust CO

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Jan 08, 2024	SELL	$24.82 - $32.88 $41,374 - $54,810	-1,667 Reduced 17.88%	7,656 $248,000
Q3 2023 Nov 17, 2023	BUY	$21.97 - $33.8 $204,826 - $315,117	9,323 New	9,323 $254,000
Q4 2017 Jan 19, 2018	SELL	$15.77 - $20.72 $413,174 - $542,864	-26,200 Closed	0 $0
Q3 2017 Oct 17, 2017	BUY	$12.3 - $19.3 $322,260 - $505,660	26,200	26,200 $506,000

350

86.1M

1.12M

667K

Ticker CORT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 107,105,000
Market Cap $5.92B
Description
Corcept Therapeutics Incorporated discovers, develops, and commercializes drugs for the treatment of severe metabolic, oncologic, and neuropsychiatric disorders in the United States. The company offers Korlym (mifepristone) tablets as a once-daily oral medication for the treatment of hyperglycemia secondary to hypercortisolism in adult patients ...

Get notified when there are updates to the investment portfolio of Diversified Trust CO, based on Form 13F filings with the SEC.

Stay updated on Diversified Trust CO with notifications on news.